Result of General Meeting

BioPharma Credit PLC

28 December 2023

 

BIOPHARMA CREDIT PLC

(THE "COMPANY")

RESULT OF GENERAL MEETING

The Company is pleased to announce that, at the General Meeting held today, the resolution put to the meeting was passed by way of a poll.

Resolution	Votes For	%	Votes Against	%	Votes Withheld1
To approve the continuation of the Company's business as a closed-ended investment trust.	704,196,309	94.06	44,493,800	5.94	21,716

1.     A 'vote withheld' is not a vote under English law and is not counted in the calculation of votes 'for' or 'against' a resolution.

A copy of the resolution has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

28 December 2023

Enquiries

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

T. [phone]  

Buchanan

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

[phone]

[e-mail]

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

 

END